Pharmaceutical and healthcare companies are among the most analysed and evaluated organisations in business today. In recent years, profitability has been lagging as many companies have been unable to sustain the robust growth that was once a hallmark of the industry. Thinning pipelines, growing generic competition, and skyrocketing operating and marketing costs are among some of the industry’s main concerns.

Pressure is also mounting on the healthcare industry which has been characterised by rising costs, global competition induced by medical tourism and telemedicine, a growing imbalance of supply and demand as well as increasing customer demands in the recent decade. Demand is driving the system and flipping the traditional paradigm in which many health systems attempted to control costs by controlling supply. Our pharmaceutical and healthcare industry professionals provide assurance, tax and business advisory services that are